News & HighlightsNews
New study reveals gut segments organized by function, and opportunities for better drug design
New findings provide insights about how the intestine maximizes nutrient uptake, while at the same time protecting the body from potentially dangerous microbes.
Cellular rivalry promotes healthy skin development
Scientists have discovered a curious phenomenon taking place in mouse skin: cells compete with one another for the chance to develop into mature tissue. The findings indicate that this antagonism is key to creating healthy skin.
Researchers find genetic link to tuberculosis
Rockefeller scientists have identified a genetic condition that makes people prone to developing tuberculosis. In a British population, they found that the condition underlies one percent of cases of the disease—a finding that may ultimately lead to new treatment options.
Study explores genetic differences among people’s gut microbes, and their health consequences
Scientists have found that small genetic differences can cause the same gut microbe to behave differently in different people, and affect the overall health of their human hosts.
Research on repetitive worm behavior may have implications for understanding human disease
Studying microscopic worms, Rockefeller scientists have identified a brain circuit that drives repetitive behavior—providing potential clues for understanding some human psychiatric conditions.
Study pinpoints what causes relapse after cancer immunotherapy
In many cancer patients who have been treated with immunotherapy, the tumor comes back. New research identifies the cells responsible for thwarting the treatment and offers new insights into how they do it.
Gene-editing technique opens door for HIV vaccine
Researchers successfully modified immune cells to produce antibodies that fight HIV. This strategy could eventually be used to develop a vaccine against the virus, among other conditions.
New microscopy technique peers deep into the brain
Using new imaging technology, researchers can now record the activity of large populations of brain cells with unprecedented speed, and at new depths.
New hope for treating a childhood brain cancer
Recent research has shown that a drug known as MI-2 can kill cells that cause a fatal brain cancer. But only now have scientists been able to explain how the compound works: by targeting cholesterol production in tumors.
New approach to treating gastrointestinal disease patches up leaky intestines
Researchers have discovered a new compound that helps fortify the intestine's inner lining, which becomes porous in inflammatory bowel diseases.  
View
View